Abstracts: Therapeutics
Therapeutics
- ANZCOSS – the first 2000 cases
- Clinical-microbiological substantiaon of “Antoxide”application in the complex therapy of parodont and mouth cavity mucous membrane diseases
- Combined efficacy of clarithromycin plus vancomycin in mice with device-related infection by biofilms-forming Staphylococcus aureus
- Effect of the ozone applied therapy upon staphylococcal microflora and pathogens
- Excess mortality from Staphlococcus aureus bacteraemia (SAB) in a tropical setting necessitates the development of a management algorithm for resource-limited countries
- In-vitro synergistic activity of daptomycin combined with genetically recombinant antibody against MRSA
- Influence of vancomycin MIC on the clinical outcomes in patients with Staphylococcus aureus bacteremia
- Spectrum of neutralizing activity against staphylococcal and streptococcal superantigens in IVIG preparations and human plasma
- The potential of the cationic peptide A415 as a topical therapeutic agent for treating Staphylococcus aureus
9 abstracts